AUTM Newsbrief
Mar. 28, 2013

Jeopardizing US Drug Development
IPWatchdog
Sen. Ron Wyden, D-Ore., is a man with an idea for lowering health care costs. Unfortunately, it's an idea which proved disastrous the last time it was forced on the National Institutes of Health. But that hasn't dissuaded the Senator from trotting it out again. He believes if a company commercializes a new drug whose development is in some way related to a cooperative R&D agreement it had at one time with NIH, that the government can then insure "a reasonable relationship between the pricing of a licensed product, the public investment in that product and the health and safety needs of the public."More

Sen. Ron Wyden's Proposal Will Kill NIH-Pharma Collaboration
Forbes
When the Federal Technology Transfer Act passed in 1986, it allowed government laboratories like the National Institutes of Health to enter into Cooperative Research and Development Agreements with the pharmaceutical industry. Unfortunately, the collaborations envisioned by the passing of the FTTA were not immediately forthcoming. Now, however, all of that may be coming to an end. U.S. Sen. Ron Wyden has urged the NIH to reexamine its policies to protect the interest of taxpayers.More

Predicting Spinoff Success
The New York Academy of Sciences
New spinoff companies, based on intellectual property stemming from university R&D, offer a promising vehicle for technology commercialization and have the potential to generate jobs, and even enhance the quality of traditional faculty responsibilities. Furthermore, university, state and federal policymakers are increasingly seeking ways to encourage the establishment of university spinoff companies and support their growth. A recent study examines factors of success among university spinoffs, offering practical insights for entrepreneurs, policymakers and scholars alike.More

New Discovery May Allow Scientists to Make Fuel From CO2 in the Atmosphere
University of Georgia via PhysOrg
Excess carbon dioxide in the Earth's atmosphere created by the widespread burning of fossil fuels is the major driving force of global climate change, and researchers the world over are looking for new ways to generate power that leaves a smaller carbon footprint. Now, researchers at the University of Georgia have found a way to transform the carbon dioxide trapped in the atmosphere into useful industrial products.More

Canada Puts Commercialization Ahead of Blue-sky Research
Nature
Canadian finance minister, Jim Flaherty, released the country's 2013 budget, calling it "a plan for jobs, growth and long-term prosperity," words that will please some of the budget's main beneficiaries: those working in applied research. The focus on commercialization of research is not unexpected, says Mehrdad Hariri, chief executive of the Canadian Science Policy Center in Toronto. "The government has made it very clear that they want to focus on business innovation," he said. "This is an area where Canada has been slowing down."More

Fingerprint-resistant Touchscreen Coating From Queen's U Gets 'Thumbs Up'
Electronic Products and Technology
Ontario Centers of Excellence of Toronto is investing $200,000 in a Queen's University innovation that could soon make smudgy tablet and smartphone touchscreens a thing of the past. The coating has shown promise in repelling undesired water- and oil-based deposits from a wide range of surfaces, including glass, metals, wood, ceramics, plastics, fabrics, fibers and paper.More

Patent Bonanza is Bad for Business
CBS News
If you thought that overly broad patents were flooding the business world and often undercutting innovation and competition, you've only seen the beginning. According to a study from the University of Richmond School of Law, the effective percentage of patent applications granted in the U.S. reached 89 percent last year.More

How to Neuter Patent Trolls
Bloomberg Businessweek
The Shield Act singles out non-practicing entities (NPEs) as the only losing plaintiffs in patent-infringement suits that would have to pay defendants' legal costs. Moreover, it focuses on NPEs when not all NPEs are patent trolls, and some practicing entities are bigger offenders.More

Time to Take a Stand
IP Watchdog
Some say you're too focused on making money, some say you're not focused enough, some don't believe it's moral for universities to work with industry, and many have built very successful careers launching attack after attack on Bayh-Dole and the very patent system itself. And they are not going away.More

Getting Your Innovation Story to Journalists Who Care
IP Watchdog
Detractors want to change the technology transfer system regardless of how wildly successful it has been. What's more disturbing is that many want to change it back to the way it was before Bayh-Dole was enacted in 1980.More

Advocacy Alert: Tell Sen. Wyden That Taxpayers Already Receive a Return on Investment
AUTM
In a recent letter to NIH Director Dr. Francis S. Collins, Sen. Ron Wyden, D-Ore., has implored the NIH to reconsider its policies to require consideration of the public interest in the pricing of drugs developed under NIH collaborative research and development agreements (CRADA) with industry. Read AUTM President Sean Flanigan's blog on the subject here.

AUTM is urging members to meet with their federal relations colleagues and write to Sen. Wyden. Send your own letter, or customize this template letter.More

AUTM Licensing Activity Survey: FY 2012
AUTM
Data collection is underway for the AUTM Licensing Activity Survey: FY2012. Compiled annually since 1991, the survey includes quantitative data and real-world examples about licensing activities at U.S. and Canadian universities, hospitals and research institutions. All U.S. and Canadian academic institutions are encouraged to participate.

This year's survey report will be available free of charge to survey participants, and survey participants will have free access for one year (2014) to the Statistics Access for Tech Transfer (STATT) database. When the AUTM Licensing Activity Survey: FY2012 is published, members whose institutions did not contribute information to the survey will incur a charge to access the survey report and the STATT database.

Data collection for the FY2012 survey will conclude on April 25. If your institution has not received an invitation to participate, and would like to become a part of this valuable resource, contact the survey administrator.More

AUTM/NCET2 Supplemental Startup Survey: FY 2012
AUTM
For the second consecutive year, AUTM is partnering with the National Council for Entrepreneurial Tech Transfer (NCET2) to conduct a Supplemental Startup Survey that quantifies the economic impact of technology transfer. The survey asks members to report the identities of their 2012 startups and basic information on the technologies that they licensed. The output from the AUTM-NCET2 project is an interactive map showing the location of the startups, filterable by year and originating institution.

Data collection for the Supplemental Startup Survey: FY2012 is underway and concludes on April 25. You must participate in the survey to have your institution represented on the map. If you would like more information on how to participate, please contact the survey administrator.More

AUTM Webinars
AUTM
AUTM Professional Development Webinars provide year-round education for technology transfer students and professionals.

Upcoming Webinars:
March 26, Noon-1 p.m. EDT
How You Can Apply for the i6 Challenge Grant

April 26, Noon-1:30 p.m. EDT
Introduction to Chinese Law and Patent Enforcement

May 30, Noon-1:30 p.m. EDT
Social Media Training: How to Effectively Implement & Evaluate Your Social Media Strategy

June 6, Noon-1:30 p.m. EDT
U.S. Patent Application Process — From Start to Finish

June 18, Noon-1:30 p.m. EDT
Small Technology Transfer Offices: Making a Little Go a Long Way

Aug. 21, Noon-1:30 p.m. EDT
Negotiation of License Agreements
More